Intracellular localization of fibronectin by immunoelectron microscopy

Prior research has shown fibronectin to be a major extracellular glycoprotein in fibroblasts. However, little was known about its intracellular distribution at the ultrastructural level. Established methods for extracellular matrix protein localization had not resolved intracellular compartments. This gap motivated researchers to explore fibronectin's subcellular localization. The plasma membrane's role in fibronectin distribution remained unclear. Earlier studies focused on extracellular fibril formation rather than intracellular trafficking. No prior work had resolved fibronectin's presence in organelles like the Golgi. The need to understand fibronectin's intracellular journey arose from gaps in secretion pathway knowledge. This study aimed to clarify fibronectin's localization in cultured fibroblasts.

The aim of this study was to determine fibronectin's intracellular localization in chick embryo fibroblasts. Researchers sought to identify organelles where fibronectin accumulates. The specific problem addressed was the lack of ultrastructural data on fibronectin trafficking. Motivation came from the need to understand secretion pathway dynamics. Fibronectin's extracellular and intracellular roles required clarification. The study aimed to test whether fibronectin localizes in the endoplasmic reticulum or Golgi. Researchers wanted to assess how protein synthesis inhibitors affect fibronectin distribution. The goal was to provide the first ultrastructural evidence of fibronectin localization.

The study used immunoelectron microscopy with affinity-purified fibronectin antibodies. Researchers applied a ferritin bridge procedure for ultrastructural localization. Cultured chick embryo fibroblasts were the primary model system. Quantitative analysis was performed on various organelles. Protein synthesis inhibitors were used to assess fibronectin trafficking. Cycloheximide and pactamycin were tested for their effects on fibronectin localization. Labeling patterns were compared between treated and untreated cells. The method focused on detecting fibronectin in the endoplasmic reticulum and Golgi.

Fibronectin labeling was primarily observed in the rough endoplasmic reticulum and Golgi apparatus. Extracellular labeling occurred in aggregates and fibrils but not on plasma membranes. Protein synthesis inhibitors reduced fibronectin in the endoplasmic reticulum by 50%. Recovery occurred after cycloheximide removal, reaching 85% of control levels. The Golgi apparatus showed similar but smaller reductions in fibronectin labeling. Quantitative data confirmed fibronectin's intracellular localization in these organelles. No significant labeling was found in other intracellular compartments. These findings suggest fibronectin trafficking involves the endoplasmic reticulum and Golgi.

The authors propose that fibronectin is localized in the endoplasmic reticulum and Golgi apparatus. They suggest fibronectin trafficking is affected by protein synthesis inhibitors. The findings indicate fibronectin is not present on plasma membranes. Recovery after cycloheximide removal suggests dynamic fibronectin trafficking. The study concludes fibronectin is primarily intracellular in fibroblasts. The results suggest fibronectin localization is sensitive to protein synthesis. The authors propose fibronectin trafficking involves the endoplasmic reticulum and Golgi. These findings provide the first ultrastructural evidence of fibronectin localization.